Should vitamin K be supplemented instead of antagonised in patients with idiopathic pulmonary fibrosis?

Bart De Brouwer*, Ianthe Piscaer, Jan H. Von Der Thusen, Jan C. Grutters, Roger E. G. Schutgens, Emiel F. M. Wouters, Rob Janssen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)169-175
Number of pages7
JournalExpert Review of Respiratory Medicine
Volume12
Issue number3
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • Coagulation
  • idiopathic pulmonary fibrosis
  • matrix Gla protein
  • pulmonary ossifications
  • vitamin K antagonists
  • vitamin K supplementation
  • MATRIX GLA-PROTEIN
  • DEPENDENT CARBOXYLATION
  • CORONARY CALCIFICATION
  • ORAL ANTICOAGULANTS
  • VASCULAR-DISEASE
  • HUMAN HEALTH
  • LUNG
  • INHIBITOR
  • THROMBIN
  • RISK

Cite this